We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$50.8B
AUM Growth
-$294M
Cap. Flow
-$328M
Cap. Flow %
-0.65%
Top 10 Hldgs %
22.21%
Holding
1,137
New
127
Increased
273
Reduced
442
Closed
122

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$255M
2
TXT icon
Textron
TXT
+$206M
3
AZN icon
AstraZeneca
AZN
+$164M
4
XOM icon
ExxonMobil
XOM
+$124M
5
MRNA icon
Moderna
MRNA
+$121M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$962M
2
WORK
Slack Technologies, Inc.
WORK
+$204M
3
DVN icon
Devon Energy
DVN
+$201M
4
PRAH
PRA Health Sciences, Inc.
PRAH
+$170M
5
CARR icon
Carrier Global
CARR
+$155M

Sector Composition

Rank Sector Weight
1 Technology 22.3%
2 Healthcare 15.98%
3 Financials 14.49%
4 Consumer Discretionary 11.52%
5 Communication Services 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROL icon
751
Rollins
ROL
$18.1B
$8.24M 0.02%
233,250
-3,500
-1% -$131K
RXDX
752
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$8.23M 0.02%
347,315
-27,685
-7% -$653K
DICE
753
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$8.19M 0.02%
+250,000
New +$8.51M
ARCH
754
DELISTED
Arch Resources, Inc.
ARCH
$8.15M 0.02%
87,856
-173,028
-66% -$12.2M
NMMC
755
DELISTED
North Mountain Merger Corp. Class A Common Stock
NMMC
$8.12M 0.02%
829,742
– –
MP icon
756
MP Materials
MP
$8.53B
$8.06M 0.02%
+250,000
New +$8.69M
SYRS
757
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$8.05M 0.02%
180,000
+94,770
+111% +$4.63M
MDGL icon
758
Madrigal Pharmaceuticals
MDGL
$11.9B
$7.98M 0.02%
100,000
– –
FPAC
759
DELISTED
Far Peak Acquisition Corporation
FPAC
$7.96M 0.02%
800,000
-200,000
-20% -$1.99M
PBCT
760
DELISTED
People's United Financial Inc
PBCT
$7.94M 0.02%
454,673
-6,600
-1% -$107K
EWBC icon
761
East-West Bancorp
EWBC
$18.3B
$7.94M 0.02%
102,351
-81,025
-44% -$5.9M
OBIO icon
762
Orchestra BioMed
OBIO
$253M
$7.91M 0.02%
800,000
– –
DY icon
763
Dycom Industries
DY
$12.3B
$7.91M 0.02%
+111,000
New +$7.85M
IMGO
764
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$7.9M 0.02%
+394,586
New +$8.47M
GL icon
765
Globe Life
GL
$14.3B
$7.89M 0.02%
+88,600
New +$8.28M
DISCK
766
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$7.82M 0.02%
322,151
-4,700
-1% -$126K
ALK icon
767
Alaska Air
ALK
$5.81B
$7.79M 0.02%
132,900
-216,512
-62% -$12.5M
MSAC
768
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$7.7M 0.02%
790,000
– –
CLIM
769
DELISTED
Climate Real Impact Solutions II Acquisition Corporation
CLIM
$7.7M 0.02%
787,500
-312,500
-28% -$3.05M
CWAN
770
DELISTED
Clearwater Analytics
CWAN
$7.68M 0.02%
+300,000
New +$7.7M
OTIC
771
DELISTED
Otonomy, Inc.
OTIC
$7.68M 0.02%
4,000,000
+500,000
+14% +$848K
NGC
772
DELISTED
Northern Genesis Acquisition Corp. III
NGC
$7.64M 0.02%
787,500
-112,500
-13% -$1.1M
ZION icon
773
Zions Bancorporation
ZION
$10.5B
$7.63M 0.02%
123,286
+22,500
+22% +$1.24M
TPTX
774
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$7.63M 0.02%
114,822
-85,178
-43% -$6.07M
NLSN
775
DELISTED
Nielsen Holdings plc
NLSN
$7.38M 0.01%
384,548
+294,500
+327% +$6.56M
29 30
31
32 33

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Adage Capital Partners held 1,137 positions worth $50.8B, down 0.58% from $51.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Adage Capital Partners's Q3 2021 filing shows 127 new, 273 increased, 442 reduced and 122 closed positions. Its largest new stake was Pfizer: 5,759,101 shares worth $248M. The largest sale was Alexion Pharmaceuticals, an estimated $962M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2021 buy was Pfizer: 5,759,101 shares worth $248M.
  • Adage Capital Partners added most to Textron in Q3 2021, an estimated $206M increase.
  • Adage Capital Partners's biggest Q3 2021 reduction was Devon Energy, cutting an estimated $201M.
  • Adage Capital Partners fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $962M.
  • Adage Capital Partners's ten largest holdings make up 22% of its $50.8B portfolio in Q3 2021.
  • Adage Capital Partners opened 127 new positions and closed 122 in Q3 2021.
  • Adage Capital Partners's portfolio value fell 0.58% quarter-over-quarter to $50.8B.

Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.